Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3309 of 6351
-
Smart scans guide radiation to zap rectal cancer more precisely
Disease control OngoingThe purpose of the study is to determine the feasibility of using magnetic resonance imaging (MRI)-guided adaptive chemoradiation therapy to improve response to treatment.
Early phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could an old drug tame cancer in the spinal fluid? new trial aims to find out
Disease control Recruiting nowThe researchers are doing this study to find out whether deferoxamine (DFO) given intrathecally (directly into the CSF) is a safe treatment for people with leptomeningeal metastasis from solid tumor cancer. The researchers will test different doses of DFO to find the highest dose…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can exosomes predict sudden heart death? new study seeks answers
Knowledge-focused Recruiting nowAcute coronary syndrome (ACS) is one of the main causes of death. Worldwide, tens of millions of patients are hospitalized for coronary heart disease and ACS every year. ACS may show acute myocardial infarction, unstable angina pectoris, and even induce early arrhythmia, leading …
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Ice packs may cut opioid use after Kids' appendix surgery
Symptom relief CompletedThis is a randomized control trial to evaluate the efficacy of an FDA approved cold therapy device vs. usual care among children undergoing appendectomy at a large children's hospital.
Sponsor: Boston Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Could a new pill curb binge eating? phase 2 trial underway
Symptom relief CompletedThe primary objective of this study is to assess the efficacy of 2 doses of centanafadine sustained-release (SR) (200 milligrams \[mg\] and 400 mg total daily dose \[TDD\]) compared with placebo in adults with moderate to severe binge eating disorder (BED).
Phase 2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 14:59 UTC
-
New gel shields bowel during prostate radiation – could cut side effects
Symptom relief OngoingTo demonstrate the effectiveness of the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate cancer.
Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
New Drug-Radiation combo shows promise for Tough-to-Treat head and neck cancer
Disease control OngoingThis phase I trial investigates the side effects and best dose of peposertib when given together with radiation therapy in treating patients with head and neck cancer that has spread to other places in the body (advanced) who cannot take cisplatin. Peposertib may stop the growth …
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New heart device for babies: safer alternative to surgery?
Disease control Recruiting nowThis retrospective and prospective, multicenter, international post marketing follow up study evaluates the safety and efficacy of the Occlutech® PDA Occluder, delivered using the Occlutech Occlusions Pusher (OOP), in subjects with patent ductus arteriosus (PDA) defects. Safety a…
Sponsor: Occlutech International AB • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New trial aims to fix blood vessel damage in african americans
Disease control Recruiting nowSpecific Aim 1: To test the hypothesis that prolonged (3-month) treatment with galantamine inhibits NADPH IsoLG-protein adducts formation and improves markers of endothelial cell (EC) dysfunction in AAs. Aim 1a: The investigators will determine if galantamine inhibits NADPH IsoL…
Phase 1/2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Mouth taping for sleep apnea: simple trick or risky move?
Knowledge-focused CompletedMouth breathing is associated with increased airway resistance, pharyngeal collapsibility, and obstructive sleep apnea (OSA) severity. It is commonly believed that closing the mouth can mitigate the negative effects of mouth breathing during sleep. However, the investigators prop…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Can a computer game lift depression? new study tests digital therapy for cancer and kidney patients
Symptom relief CompletedThis is a prospective, randomized clinical study to evaluate the feasibility and efficacy of a digital neurotherapy on depression, cognition, and quality of life in two groups of patients with major medical illness: 1) a sample of cancer survivors, and 2) a sample of patients wit…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 26, 2026 17:22 UTC
-
Bronx parents get help to beat pandemic stress in new study
Symptom relief OngoingFor caregivers in the Bronx, the pandemic has caused unprecedented psychological distress; in addition to combating social determinants of health (SDOH), these families now face greater financial insecurity and challenges related to their school-aged children. Furthermore, social…
Sponsor: Albert Einstein College of Medicine • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
New targeted drug ZV0203 enters first human tests for Hard-to-Treat HER2 cancers
Disease control By invitation onlyAn open-label, multicenter, phase I dose-escalation study to assess the safety, Pharmacokinetic (PK), immunogenicity and preliminary anti-tumor activity of ZV0203 in patients with HER2-Positive advanced solid tumors
Phase 1 • Sponsor: Hangzhou Adcoris Biopharmacy Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could using an inhaler only when needed beat daily asthma pills?
Disease control OngoingInhaler nonadherence is a common problem that has been estimated to account for approximately 60% of all asthma-related hospitalizations. Unfortunately, prior interventions to improve inhaler nonadherence have shown a lack of long-term success. This study proposes to assess the p…
Phase 1/2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Virtual therapy helps kids with rare epilepsy gain daily living skills
Symptom relief CompletedThe pandemic has made it necessary to imagine and experiment with new ways for disabled patients to continue their care, responding to the sudden employment and emotional void of this historical period. With this in mind, several studies have shown how telemedicine and telerehabi…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Ketamine infusion may ease chronic nerve pain in brachial plexus injuries
Symptom relief By invitation onlyThe purpose of this study is to assess pre- and postoperative neuropathic pain in patients with traumatic brachial plexus injuries to determine if intraoperative ketamine infusion affect neuropathic pain associated with avulsion injuries of the brachial plexus.
Phase 4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Email your doctor to beat gout: new trial tests remote care
Disease control OngoingGout is secondary to urate crystal deposition after chronic elevation of serum urate level (SUL). Long-term lowering SUL below 360 µmol/L allows dissolution of deposited crystals and disease cure. There is currently a paradoxical observation: while urate-lowering therapy (ULT) is…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Bomedemstat extension trial tests Long-Term safety for blood cancer patients
Disease control CompletedThis is a multi-center, open-label extension study to assess the long-term safety and efficacy of bomedemstat administered orally once daily in participants with a Myeloproliferative Neoplasm (MPN) who participated in a prior bomedemstat study such as, but not limited to, IMG-728…
Phase 2 • Sponsor: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Tailored diets may help tame type 2 diabetes
Disease control CompletedIn a randomized trial of 255 participants with early-stage T2D, participants will be randomized to 1 of 3 groups: Standardized, Personalized, or a Usual Care Control (UCC). In the first phase, participants will be randomized with equal allocation to these 3 groups. In the second …
Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Phone app aims to help mentally ill smokers kick the habit
Symptom relief OngoingAdults with serious mental illness (SMI) represent 5% of the United States population, yet account for 30% of all cigarettes smoked and are 2 to 3 times more likely to be dependent on nicotine compared with the general population. There are also significant disparities in quittin…
Phase 2 • Sponsor: University of Oklahoma • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC